Foghorn stock down as Lilly exits collaboration (FHTX:NASDAQ)

Foghorn Therapeutics (FHTX) stock fell 43.7% after discontinuing its lead oncology asset, FHD-909, due to lack of efficacy. The company also ended a collaboration with Eli Lilly and plans a 40% workforce reduction, redirecting resources to its proprietary pipeline. The S&P 500, Dow Jones, and Nasdaq were up slightly, indicating the decline was company-specific.

Foghorn Therapeutics Inc. (FHTX) filed an SEC Form 8-K — Regulation FD Disclosure. Exhibit 99.1 Foghorn Therapeutics Provides Update on FHD-909 and Strategic Priorities – Foghorn and Lilly will not advance FHD-909; The Collaboration also will not advance the Selective SMARCA2 degrader program – Company to focus resources on wholly owned pipeline, including a Se

Foghorn Therapeutics Inc. (FHTX) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Foghorn Therapeutics Provides Second Quarter 2026 Financial and Corporate Update - FHD-909 (LY4050784) Phase 1 dose-escalation trial advancing as planned with non-small cell lung cancer (NSCLC) as the primary target population - Selective EP300 degraders with potenti

Hewlett Packard Enterprise (HPE) shares rose 1.4% premarket after Citi raised its price target to $92 from $76. The upgrade followed HPE's improved fiscal 2027 revenue growth outlook, driven by AI infrastructure demand. A $1.2 billion order from Vultr also boosted confidence. HPE's stock is currently priced at $63.89, which is 127.2% above its GF Value™ of $28.12, indicating significant overvaluation.

Enerflex (EFX) stock surged 12.3% in pre-market trading after securing a $450MW power generation contract for a North American data center and completing the sale of its Asia Pacific operations. The company plans to invest $85M to support growth, with deliveries starting in 2027. The S&P 500 and Nasdaq were up 0.4% and 0.6%, respectively.

Deutsche Bank increased its price target for Synopsys (SNPS) to $640 from $590. The move follows Synopsys' partnerships with Amazon and OpenAI, and its guidance of 15% revenue growth for fiscal 2027. SNPS shares rose 5% in premarket trading, building on Wednesday's gains.